Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans

J Infect Dis. 1992 May;165(5):920-4. doi: 10.1093/infdis/165.5.920.

Abstract

Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2-1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2-2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-1-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P less than .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-1 or syphilis were significantly more likely to be HTLV-I/II-seropositive.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Baltimore / epidemiology
  • Female
  • HIV Antibodies / blood
  • HIV Infections / epidemiology*
  • HIV-1 / immunology*
  • HTLV-I Antibodies / blood
  • HTLV-I Infections / epidemiology*
  • HTLV-II Antibodies / blood
  • HTLV-II Infections / epidemiology*
  • Humans
  • Louisiana / epidemiology
  • Male
  • Prevalence
  • Risk Factors
  • Sexually Transmitted Diseases / epidemiology*
  • Substance Abuse, Intravenous / complications

Substances

  • HIV Antibodies
  • HTLV-I Antibodies
  • HTLV-II Antibodies